Bcl3-dependent stabilization of CtBP1 is crucial for the inhibition of apoptosis and tumor progression in breast cancer

Biochemical and Biophysical Research Communications

Volumn 400, Issue 3, 2010, Pages 396-402

  Choi, Hee June ^a   Lee, Ji Min ^a   Kim, Hyunkyung ^a   Nam, Hye Jin ^a   Shin, Hi Jai R ^a   Kim, Dongha ^a   Ko, Enyoung ^b   Noh, Dong Young ^b   Kim, Keun Il ^c   Kim, Jung Hwa ^d   Baek, Sung Hee ^a  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Sookmyung Women's University   (South Korea)

^d Inha University   (South Korea)

Author keywords

Apoptosis; Bcl3; Cancer; CtBP1; Ubiquitination

Indexed keywords

C TERMINAL BINDING PROTEIN 1; DNA BINDING PROTEIN; PROTEIN BCL 3; UNCLASSIFIED DRUG; ALCOHOL DEHYDROGENASE; C-TERMINAL BINDING PROTEIN; ONCOPROTEIN; PROTO-ONCOGENE PROTEIN BCL-3; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN STABILITY; PROTEOMICS; UPREGULATION; ANTAGONISTS AND INHIBITORS; BREAST TUMOR; CELL PROLIFERATION; ENZYME STABILITY; FEMALE; METABOLISM; PATHOLOGY; TUMOR CELL LINE; UBIQUITINATION;

ALCOHOL OXIDOREDUCTASES; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; ENZYME STABILITY; FEMALE; HUMANS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; UBIQUITINATION;

EID: 77956917232     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.084     Document Type: Article

References (22)

1. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
2. Johnstone R.W., Ruefli A.A., Lowe S.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002, 108:153-164.
3. Corazzari M., Lovat P.E., Oliverio S., Di Sano F., Donnorso R.P., Redfern C.P., Piacentini M. Fenretinide: a p53-independent way to kill cancer cells. Biochem. Biophys. Res. Commun. 2005, 331:810-815.
4. Ohno H., Takimoto G., McKeithan T.W. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 1990, 60:991-997.
5. Cogswell P.C., Guttridge D.C., Funkhouser W.K., Baldwin A.S. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 2000, 19:1123-1131.
6. Ahmed S.U., Milner J. Basal cancer cell survival involves JNK2 suppression of a novel JNK1/c-Jun/Bcl-3 apoptotic network. PLoS One 2009, 4:e7305.
7. Kashatus D., Cogswell P., Baldwin A.S. Expression of the Bcl-3 proto-oncogene suppresses p53 activation. Genes Dev. 2006, 20:225-235.
8. Subramanian T., La Regina M., Chinnadurai G. Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein. Oncogene 1989, 4:415-420.
9. Chinnadurai G. CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol. Cell 2002, 9:213-224.
10. Grooteclaes M., Deveraux Q., Hildebrand J., Zhang Q., Goodman R.H., Frisch S.M. C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proc. Natl. Acad. Sci. USA 2003, 100:4568-4573.
11. Zhang Q., Yoshimatsu Y., Hildebrand J., Frisch S.M., Goodman R.H. Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 2003, 115:177-186.
12. Zhang Q., Nottke A., Goodman R.H. Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis. Proc. Natl. Acad. Sci. USA 2005, 102:2802-2807.
13. Natsume T., Yamauchi Y., Nakayama H., Shinkawa T., Yanagida M., Takahashi N., Isobe T. A direct nanoflow liquid chromatography-tandem mass spectrometry system for interaction proteomics. Anal. Chem. 2002, 74:4725-4733.
14. Dechend R., Hirano F., Lehmann K., Heissmeyer V., Ansieau S., Wulczyn F.G., Scheidereit C., Leutz A. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators. Oncogene 1999, 18:3316-3323.
15. Kim J.H., Kim B., Cai L., Choi H.J., Ohgi K.A., Tran C., Chen C., Chung C.H., Huber O., Rose D.W., Sawyers C.L., Rosenfeld M.G., Baek S.H. Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature 2005, 434:921-926.
16. Grooteclaes M.L., Frisch S.M. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 2000, 19:3823-3828.
17. Carmody R.J., Ruan Q., Palmer S., Hilliard B., Chen Y.H. Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. Science 2007, 317:675-678.
18. Keutgens A., Shostak K., Close P., Zhang X., Hennuy B., Aussems M., Chapelle J.P., Viatour P., Gothot A., Fillet M., Chariot A. The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1. Mol. Cell Biol. 2010, 30:4006-4021.
19. O'Neil B.H., Buzkova P., Farrah H., Kashatus D., Sanoff H., Goldberg R.M., Baldwin A.S., Funkhouser W.K. Expression of nuclear factor-kappaB family proteins in hepatocellular carcinomas. Oncology 2007, 72:97-104.
20. Thornburg N.J., Pathmanathan R., Raab-Traub N. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res. 2003, 63:8293-8301.
21. Wang S.Y., Iordanov M., Zhang Q. C-Jun NH2-terminal kinase promotes apoptosis by down-regulating the transcriptional co-repressor CtBP. J. Biol. Chem. 2006, 281:34810-34815.
22. Paliwal S., Pande S., Kovi R.C., Sharpless N.E., Bardeesy N., Grossman S.R. Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis. Mol. Cell Biol. 2006, 26:2360-2372.